274 related articles for article (PubMed ID: 36734528)
1. Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis.
Smith S; Calthorpe R; Herbert S; Smyth AR
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013733. PubMed ID: 36734528
[TBL] [Abstract][Full Text] [Related]
2. Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis.
Dawson S; Girling CJ; Cowap L; Clark-Carter D
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013766. PubMed ID: 36989170
[TBL] [Abstract][Full Text] [Related]
3. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
Southern KW; Solis-Moya A; Kurz D; Smith S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
[TBL] [Abstract][Full Text] [Related]
4. Short-acting inhaled bronchodilators for cystic fibrosis.
Smith S; Rowbotham NJ; Edwards CT
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013666. PubMed ID: 35749226
[TBL] [Abstract][Full Text] [Related]
5. Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.
Jones M; Moffatt F; Harvey A; Ryan JM
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD013610. PubMed ID: 37462324
[TBL] [Abstract][Full Text] [Related]
6. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Smith S; Rowbotham NJ
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
[TBL] [Abstract][Full Text] [Related]
7. Exercise versus airway clearance techniques for people with cystic fibrosis.
Heinz KD; Walsh A; Southern KW; Johnstone Z; Regan KH
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013285. PubMed ID: 35731672
[TBL] [Abstract][Full Text] [Related]
8. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM; Smith S
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD001506. PubMed ID: 37319354
[TBL] [Abstract][Full Text] [Related]
9. Digital technology for early identification of exacerbations in people with cystic fibrosis.
Wong CH; Smith S; Kansra S
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD014606. PubMed ID: 37057835
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
[TBL] [Abstract][Full Text] [Related]
12. Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis.
Pinto ACPN; Piva SR; Rocha A; Gomes-Neto M; Atallah ÁN; Saconato H; Trevisani VF
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014605. PubMed ID: 37294546
[TBL] [Abstract][Full Text] [Related]
13. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smith S; Rowbotham NJ; Yule A; Smyth AR
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD004197. PubMed ID: 37268599
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Smith S; Lykkesfeldt J
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
[TBL] [Abstract][Full Text] [Related]
16. Probiotics for people with cystic fibrosis.
Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
[TBL] [Abstract][Full Text] [Related]
17. Nebuliser systems for drug delivery in cystic fibrosis.
Stanford G; Morrison L; Brown C
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007639. PubMed ID: 37942828
[TBL] [Abstract][Full Text] [Related]
18. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008319. PubMed ID: 35914011
[TBL] [Abstract][Full Text] [Related]
19. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright CE; Smyth AR
Cochrane Database Syst Rev; 2024 May; 5(5):CD009530. PubMed ID: 38700027
[TBL] [Abstract][Full Text] [Related]
20. Long-acting inhaled bronchodilators for cystic fibrosis.
Smith S; Edwards CT
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012102. PubMed ID: 29253920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]